Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Pemoline measurement |
Component |
True |
Pemoline (substance) |
Inferred relationship |
Some |
1 |
Pemoline adverse reaction |
Causative agent (attribute) |
True |
Pemoline (substance) |
Inferred relationship |
Some |
1 |
Allergy to pemoline (finding) |
Causative agent (attribute) |
False |
Pemoline (substance) |
Inferred relationship |
Some |
|
Pemoline 18.75 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pemoline (substance) |
Inferred relationship |
Some |
|
Pemoline 37.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pemoline (substance) |
Inferred relationship |
Some |
|
Pemoline 75 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pemoline (substance) |
Inferred relationship |
Some |
|
Product containing pemoline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pemoline (substance) |
Inferred relationship |
Some |
1 |
Product containing methyltestosterone and pemoline and yohimbine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pemoline (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pemoline (substance) |
Inferred relationship |
Some |
|
Product containing precisely pemoline 37.5 milligram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pemoline (substance) |
Inferred relationship |
Some |
|
Allergy to pemoline (finding) |
Causative agent (attribute) |
True |
Pemoline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pemoline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pemoline (substance) |
Inferred relationship |
Some |
1 |
Pemoline 18.75 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pemoline (substance) |
Inferred relationship |
Some |
1 |
Pemoline 18.75 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pemoline (substance) |
Inferred relationship |
Some |
1 |
Pemoline 37.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pemoline (substance) |
Inferred relationship |
Some |
1 |
Pemoline 37.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pemoline (substance) |
Inferred relationship |
Some |
1 |
Pemoline 75 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pemoline (substance) |
Inferred relationship |
Some |
1 |
Pemoline 75 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pemoline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pemoline (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pemoline (substance) |
Inferred relationship |
Some |
2 |
Pemoline 18.75 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pemoline (substance) |
Inferred relationship |
Some |
1 |
Pemoline 37.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pemoline (substance) |
Inferred relationship |
Some |
1 |
Pemoline 75 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pemoline (substance) |
Inferred relationship |
Some |
1 |
Methyltestosterone- and pemoline- and yohimbine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pemoline (substance) |
Inferred relationship |
Some |
2 |
Product containing pemoline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pemoline (substance) |
Inferred relationship |
Some |
1 |
Product containing only methyltestosterone and pemoline and yohimbine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pemoline (substance) |
Inferred relationship |
Some |
2 |
Pemoline only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pemoline (substance) |
Inferred relationship |
Some |
1 |
Methyltestosterone and pemoline and yohimbine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pemoline (substance) |
Inferred relationship |
Some |
2 |
Pemoline only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pemoline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pemoline 37.5 milligram/1 each conventional release chewable tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pemoline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pemoline 37.5 milligram/1 each conventional release chewable tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pemoline (substance) |
Inferred relationship |
Some |
1 |